FDA's Pazdur Jumps Over To New 'Moonshot' Role

Creation of agency's new Oncology Center of Excellence means the Office of Hematology and Oncology Products, often seen as FDA's model product review shop, needs new leadership – at least temporarily.

More from Archive

More from Pink Sheet